twisted B suitable for subsequent cyclization would be
necessary.17a The anionic carbon a to the ester group in B
attacked the carbon of the imine intramolecularly from the
back side of the plane b to afford the sole a-addition product
cis-2,3-dihydrogen-4-perfluoroalkyl-1,5-benzodiazepines.
In conclusion, we have developed a novel one-pot three-
component reaction of aldehydes, o-phenylenediamines, and
methyl 2-perfluoroalkynoates in the absence of a catalyst. The
main feature of this reaction is the formation of cis-a-addition
perfluoroalkylated products. The easy work-up, mild reaction
conditions, good yields and high stereoselectivity of the
reaction make the present methodology attractive for the
preparation of a wide variety of biologically relevant 1,5-
benzodiazepines.
8 (a) M. Curini, F. Epifano, M. C. Marcotullio and O. Rosati,
Tetrahedron Lett., 2001, 42, 3193; (b) S. K. De and R. A. Gibbs,
Tetrahedron Lett., 2005, 46, 1811.
9 (a) M. S. Balakrishna and B. Kaboudin, Tetrahedron Lett., 2001,
42, 1127; (b) M. Pozarentzi, J. S. Stephanatou and C. A. Tsoleridis,
Tetrahedron Lett., 2002, 43, 1755; (c) B. Das, R. Ramu,
B. Ravikanth and V. S. Reddy, J. Mol. Catal. A: Chem., 2006,
76, 246; (d) H. Thakuria, A. Pramanik, B. M. Borah and G. Das,
Tetrahedron Lett., 2006, 47, 3135; (e) R. Kumar and Y. C. Joshi,
ARKIVOC, 2007, 13, 142.
10 (a) K. Murai, R. Nakatani, Y. Kita and H. Fujioka, Tetrahedron,
2008, 64, 11034; (b) X.-Q. Pan, J.-P. Zou, Z.-H. Huang and
W. Zhang, Tetrahedron Lett., 2008, 49, 5302; (c) B. Willy,
T. Dallos, F. Rominger, J. Schonhaber and T. J. J. Muller, Eur.
J. Org. Chem., 2008, 4796; (d) W.-Y. Chen and J. Lu, Synlett, 2005,
1337; (e) A. Alizadeh, N. Zohreh and L.-G. Zhu, Tetrahedron,
2009, 65, 2684; (f) P. Goswami and B. Das, Synth. Commun., 2010,
40, 1685.
The authors are grateful to the National Natural Science
Foundation of China (Grant Nos 20872088, 21072126) and
The Leading Academic Discipline Projects of Shanghai
Municipal Education Commission (Grant No. J50102) for
their financial support. We also thank Dr Jonathan F. Lovell
for his editing.
11 (a)
Organofluorine
Chemistry:
Principles
and
Commercial Applications, ed. R. E. Banks, B. E. Smart and
J. C. Tatlow, Plenum Press, New York, 1994; (b) Organofluorine
Compounds in Medicinal Chemistry and Biomedical Applications,
ed. R. Filler, Y. Kobayashi and L. M. Yagupolskii, Elsevier,
Amsterdam, 1993.
12 (a) N. Ishikawa and A. Takaoka, Eur. Pat. Appl., 133322, 1985;
(b) E. Zouaoui, G. El and M. Mohamed, J. Chem. Res. (S), 2003,
242; (c) E. Okada, N. Tsukushi, N. Kunihiro and Y. Tomo,
Heterocycles, 1998, 49, 297; (d) E. Okada, N. Tsukushi and
N. Shimomura, Synthesis, 2000, 1822; (e) D. S. Yachevskii,
D. L. Chizhov, M. I. Kodess and K. I. Pashkevich, Monatsh.
Chem., 2004, 135, 23; (f) A. C. S. Reddy, P. S. Rao and
R. V. Venkataratnam, Tetrahedron, 1997, 53, 5847; (g) N. Ota,
Notes and references
z Unit cell parameters: a: 8.825(6) A; b: 9.598(7) A; c: 12.295(9) A;
a: 88.156(10)1; b: 70.934(9)1; g: 63.004(8)1; space group: P-1.
1 (a) A. M. El-Sayed, H. Abdel-Ghany and A. M. M. El-Saghier,
Synth. Commun., 1999, 29, 3561; (b) M. Essaber, A. Baouid,
A. Hasnaoui, A. Benharref and J.-P. Lavergne, Synth. Commun.,
1998, 28, 4097; (c) K. V. V. Reddy, P. S. Rao and D. Ashok, Synth.
Commun., 2000, 30, 1825; (d) M. Di Braccio, G. Grossi, G. Roma,
L. Vargiu, M. Mura and M. E. Marongiu, Eur. J. Med. Chem.,
2001, 36, 935.
T. Tomoda, N. Terai, Y. Kamitori, D. Shibata, M. Me
E. Okada, Heterocycles, 2008, 76, 1205.
´
debielle and
13 (a) L. Lu, J. Wei, J. Chen, J. Zhang, H. Deng, M. Shao, H. Zhang
and W. Cao, Tetrahedron, 2009, 65, 9152; (b) L. Lu, W. Cao,
J. Chen, H. Zhang, J. Zhang, H. Chen, J. Wei, H. Deng and
M. Shao, J. Fluorine Chem., 2009, 130, 295.
14 Z. A. Nauk, Izv. Akad. Nauk. SSSR, Ser. Khim., 1985, 1, 144.
15 B. C. Hamper, Org. Synth., 1992, 70, 246.
2 L. Chen, Y.-L. Zhao, C. Cheng and C.-R. Piao, J. Org. Chem.,
2007, 72, 9259.
16 For recent reviews, see: (a) A. Domling, Chem. Rev., 2006, 106, 17;
¨
3 (a) O. Randall and B. Kappel, in Benzodiazepines, ed. S. Garattini,
E. Mussini and L. O. Randall, Raven Press, New York, 1973,
p. 27; (b) H. Schutz, Benzodiazepines, Springer, Heidelberg, 1982.
4 (a) S. K. Ha, D. Shobha, E. Moon, M. A. Chari, K. Mukkanti,
S.-H. Kim, K.-H. Ahn and S. Y. Kim, Bioorg. Med. Chem. Lett.,
2010, 20, 3969; (b) J. G. Ghogare, S. V. Bhandari, K. G. Bothara,
A. R. Madgulkar, G. A. Parashar, B. G. Sonawane and
P. R. Inamdar, Eur. J. Med. Chem., 2010, 45, 857.
5 R. C. Harris and J. M. Straley, US Pat., 1,537,757, 1968;
R. C. Harris and J. M. Straley, Chem. Abstr., 1970, 73, 100054w.
6 W. Ried and P. Stahlhofen, Chem. Ber., 1957, 90, 815.
7 W. Ried and E. Torinus, Chem. Ber., 1959, 92, 2902.
(b) L. Banfi and R. Riva, Org. React., 2005, 65, 1; (c) D. J. Ramon
and M. Yus, Angew. Chem., 2005, 117, 1628 (Angew. Chem., Int.
Ed., 2005, 44, 1602); (d) K. Kumaravel and G. Vasuki, Curr. Org.
Chem., 2009, 13, 1820; (e) D. M. D’Souza and T. J. Mueller, Chem.
Soc. Rev., 2007, 36, 1095; (f) S. Dandapani and L. Marcaurelle,
Curr. Opin. Chem. Biol., 2010, 14, 362.
17 (a) N. Ota, Y. Kamitori, T. Tomoda, N. Terai and E. Okada,
Heterocycles, 2009, 77, 461; (b) P. Stahlofen and W. Ried, Chem.
Ber., 1957, 90, 815; (c) W. Ried and E. Torinus, Chem. Ber., 1959,
92, 2902; (d) J. A. L. Herbert and H. Suschitzky, J. Chem. Soc.,
Perkin Trans. 1, 1974, 2657; (e) H. R. Morales, A. Bulbarela and
R. Contreras, Heterocycles, 1986, 24, 135.
c
This journal is The Royal Society of Chemistry 2011
Chem. Commun., 2011, 47, 3607–3609 3609